Company description

ACME is a leading manufacturer of Tablets, Capsules, Injectables, Oral Contraceptives & Levothyroxine Tabs.
Our sites are approved by EU GMP, UK-MHRA, PICS, INVIMA, ANVISA, FDA Philippines, DAV Vietnam Ethiopia, Tanzania, WHO Geneva. Triggered: TGA Australia, Health Canada and US FDA by filing planned in Q1 2018. 

CTD Dossiers for Licensing
Contract Manufacturing Services
Contract Development& Research
Asia: Nepal, Sri Lanka, Philippines, Vietnam, Cambodia, Laos, Thailand, Yemen, Myanmar 
Africa: Ethiopia, Nigeria, Ghana, Tanzania, Kenya, Uganda, Zambia, Malawi, Nigeria, Sierra Leone, Madagascar, Angola, Zimbabwe, Mozambique, Cameroon, Senegal, South Sudan
North America: US  & Canada (Filing planned in Q1 2018) 
Europe: United Kingdom, Hungary
South America: Brazil, Colombia, Guatemala, Nicaragua, Paraguay, Uruguay, Chile, Costa Rica, Venezuela, Peru
CIS: Kazakhstan, Uzbekistan, Ukraine
ANZ: Australia
Responsibility of product patents lies with the buyer of the country
For more details please visit our website: www.acmeformulation.com& www.immacule.in 

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Contract Manufacturer; Exporter; Manufacturer
Affiliated categories: Aseptic technology |Capsules |Contract Manufacturing More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 1A22 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 91A57 See our Exhibitor Profile   See full Exhibitor List
Acme Generics LLP

Contact information




View all contact information